{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:59:06Z","timestamp":1792159146146,"version":"4.4.0"},"reference-count":135,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":275,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006939","name":"EU","doi-asserted-by":"publisher","award":["PE00000007"],"award-info":[{"award-number":["PE00000007"]}],"id":[{"id":"10.13039\/100006939","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["2021\u2013ID.25899"],"award-info":[{"award-number":["2021\u2013ID.25899"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Targeted degradation is emerging as a new therapeutic approach in the treatment of different diseases. It allows hijacking the cellular pathways deputed to protein or nucleic acid homeostasis to degrade a target macromolecule of interest involved in a pathogenic process. In the last decades, targeted protein degradation has been widely applied for the treatment of cancer or neurodegenerative disorders and some of such therapies are already in clinical use. More recently, therapeutic degraders such as PROTACs, LYTACs, HyTs, BacPROTACs, and others have also been explored in the field of antimicrobial and antiviral drug discovery. The peculiar mechanism of action, along with the opportunity to degrade both microbial and host targets, holds great promise for overcoming some limitations of classic antimicrobials, e.g. drug resistance, as well as for increasing the potency of current therapies. With a focus on the antimicrobial field, this Review aims at providing a comprehensive, state-of-the-art description of targeted degradation mechanisms and strategies developed so far, as well as to discuss advantages, disadvantages, and caveats of this innovative approach for combating infectious diseases.<\/jats:p>","DOI":"10.1093\/femsre\/fuaf046","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:57:36Z","timestamp":1759406256000},"source":"Crossref","is-referenced-by-count":9,"title":["PROteolysis TArgeting Chimeras (PROTACs) and beyond: targeted degradation as a new path to fight microbial pathogens"],"prefix":"10.1093","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9588-1274","authenticated-orcid":false,"given":"Alessandro","family":"Bazzacco","sequence":"first","affiliation":[{"name":"University of Padua Department of Molecular Medicine, , 35121 Padua ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0654-8045","authenticated-orcid":false,"given":"Beatrice","family":"Mercorelli","sequence":"additional","affiliation":[{"name":"University of Padua Department of Molecular Medicine, , 35121 Padua ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8900-861X","authenticated-orcid":false,"given":"Arianna","family":"Loregian","sequence":"additional","affiliation":[{"name":"University of Padua Department of Molecular Medicine, , 35121 Padua ,","place":["Italy"]},{"name":"Microbiology and Virology Unit, Padua University Hospital , 35121 Padua ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"2025102411450951800_bib1","doi-asserted-by":"publisher","first-page":"6495","DOI":"10.1021\/acs.jmedchem.3c02416","article-title":"Discovery of first-in-class PROTAC degraders of SARS-CoV-2 main protease","volume":"67","author":"Alugubelli","year":"2024","journal-title":"J Med Chem"},{"key":"2025102411450951800_bib2","doi-asserted-by":"publisher","first-page":"128636","DOI":"10.1016\/j.bmcl.2022.128636","article-title":"Selective Wee1 degradation by PROTAC degraders recruiting VHL and CRBN E3 ubiquitin ligases","volume":"64","author":"Aublette","year":"2022","journal-title":"Bioorg Med Chem Lett"},{"key":"2025102411450951800_bib3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","article-title":"Lysosome-targeting chimaeras for degradation of extracellular proteins","volume":"584","author":"Banik","year":"2020","journal-title":"Nature"},{"key":"2025102411450951800_bib4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41589-022-01218-w","article-title":"Targeted degradation via direct 26S proteasome recruitment","volume":"19","author":"Bashore","year":"2023","journal-title":"Nat Chem Biol"},{"key":"2025102411450951800_bib5","doi-asserted-by":"publisher","first-page":"100162","DOI":"10.1016\/j.slasd.2024.100162","article-title":"Characterisation of high throughput screening outputs for small molecule degrader discovery","volume":"29","author":"Bell","year":"2024","journal-title":"SLAS Discovery"},{"key":"2025102411450951800_bib6","doi-asserted-by":"publisher","first-page":"216331","DOI":"10.1016\/j.canlet.2023.216331","article-title":"A small molecule targeting the interaction betweenhuman papillomavirus E7 oncoprotein and cellularphosphatase PTPN14 exerts antitumoral activity incervical cancer cells","volume":"571","author":"Bertagnin","year":"2023","journal-title":"Cancer Lett"},{"key":"2025102411450951800_bib7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.chembiol.2017.09.010","article-title":"Lessons in PROTAC design from selective degradation with a promiscuous warhead","volume":"25","author":"Bondeson","year":"2018","journal-title":"Cell Chemical Biology"},{"key":"2025102411450951800_bib8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00018-025-05611-1","article-title":"Antiviral strategies against influenza virus: an update on approved and innovative therapeutic approaches","volume":"82","author":"Bonomini","year":"2025","journal-title":"Cell Mol Life Sci"},{"key":"2025102411450951800_bib9","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1021\/acsmedchemlett.1c00368","article-title":"Influence of linker attachment points on the stability and neosubstrate degradation of cereblon ligands","volume":"12","author":"Bricelj","year":"2021","journal-title":"ACS Med Chem Lett"},{"key":"2025102411450951800_bib10","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1039\/C7MD00633K","article-title":"Approaches to target tractability assessment\u2014a practical perspective","volume":"9","author":"Brown","year":"2018","journal-title":"Med Chem Commun"},{"key":"2025102411450951800_bib11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.chembiol.2017.09.009","article-title":"The advantages of targeted protein degradation over inhibition: an RTK case study","volume":"25","author":"Burslem","year":"2018","journal-title":"Cell Chemical Biology"},{"key":"2025102411450951800_bib12","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-0716-1665-9","volume-title":"Targeted Protein Degradation: Methods and Protocols","author":"Cacace","year":"2021"},{"key":"2025102411450951800_bib13","doi-asserted-by":"publisher","first-page":"7066","DOI":"10.1039\/D2CS00220E","article-title":"Chemistries of bifunctional PROTAC degraders","volume":"51","author":"Cao","year":"2022","journal-title":"Chem Soc Rev"},{"key":"2025102411450951800_bib14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canlet.2019.10.046","article-title":"A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth","volume":"470","author":"Celegato","year":"2020","journal-title":"Cancer Lett"},{"key":"2025102411450951800_bib15","doi-asserted-by":"publisher","first-page":"e03097","DOI":"10.1128\/mbio.03097-22","article-title":"Small-molecule inhibitor of flaviviral NS3-NS5 interaction with broad-spectrum activity and efficacy In vivo","volume":"14","author":"Celegato","year":"2023","journal-title":"mBio"},{"key":"2025102411450951800_bib16","doi-asserted-by":"publisher","first-page":"105480","DOI":"10.1016\/j.antiviral.2022.105480","article-title":"Targeted protein degradation as an antiviral approach","volume":"210","author":"Chakravarty","year":"2023","journal-title":"Antiviral Res"},{"key":"2025102411450951800_bib17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s42003-020-01470-7","article-title":"Targeted intracellular degradation of SARS-CoV-2 via computationally optimized peptide fusions","volume":"3","author":"Chatterjee","year":"2020","journal-title":"Commun Biol"},{"key":"2025102411450951800_bib18","doi-asserted-by":"publisher","first-page":"e01896","DOI":"10.1128\/JVI.01896-18","article-title":"HDAC6 Restricts Influenza A virus by deacetylation of the RNA polymerase PA subunit","volume":"93","author":"Chen","year":"2019","journal-title":"J Virol"},{"key":"2025102411450951800_bib19","doi-asserted-by":"publisher","first-page":"115403","DOI":"10.1016\/j.ejmech.2023.115403","article-title":"Discovery of novel BTK PROTACs with improved metabolic stability via linker rigidification strategy","volume":"255","author":"Chen","year":"2023","journal-title":"Eur J Med Chem"},{"key":"2025102411450951800_bib20","doi-asserted-by":"publisher","first-page":"116629","DOI":"10.1016\/j.ejmech.2024.116629","article-title":"Development of novel antiviral agents that induce the degradation of the main protease of human-infecting coronaviruses","volume":"275","author":"Cheng","year":"2024","journal-title":"Eur J Med Chem"},{"key":"2025102411450951800_bib21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1021\/acsmedchemlett.3c00490","article-title":"Discovery and characterization of active CBP\/EP300 degraders targeting the HAT domain","volume":"15","author":"Cheng-S\u00e1nchez","year":"2024","journal-title":"ACS Med Chem Lett"},{"key":"2025102411450951800_bib22","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.3346\/jkms.2024.39.e134","article-title":"Review of COVID-19 therapeutics by mechanism: from discovery to approval","volume":"39","author":"Choi","year":"2024","journal-title":"J Korean Med Sci"},{"key":"2025102411450951800_bib23","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1021\/jacs.0c10008","article-title":"Development of antibody-based PROTACs for the degradation of the cell-surface immune checkpoint protein PD-L1","volume":"143","author":"Cotton","year":"2021","journal-title":"J Am Chem Soc"},{"key":"2025102411450951800_bib24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.metabol.2018.01.001","article-title":"The role of extracellular and intracellular nicotinamide phosphoribosyl-transferase in cancer: diagnostic and therapeutic perspectives and challenges","volume":"82","author":"Dalamaga","year":"2018","journal-title":"Metabolism"},{"key":"2025102411450951800_bib27","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1038\/s41467-019-11429-w","article-title":"Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations","volume":"10","author":"de\u00a0Wispelaere","year":"2019","journal-title":"Nat Commun"},{"key":"2025102411450951800_bib25","doi-asserted-by":"publisher","first-page":"116202","DOI":"10.1016\/j.ejmech.2024.116202","article-title":"Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity","volume":"268","author":"Desantis","year":"2024","journal-title":"Eur J Med Chem"},{"key":"2025102411450951800_bib26","doi-asserted-by":"publisher","first-page":"113814","DOI":"10.1016\/j.ejmech.2021.113814","article-title":"Indomethacin-based PROTACs as pan-coronavirus antiviral agents","volume":"226","author":"Desantis","year":"2021","journal-title":"Eur J Med Chem"},{"key":"2025102411450951800_bib28","doi-asserted-by":"publisher","first-page":"18024","DOI":"10.1021\/acs.jmedchem.5c00949","article-title":"Phenotypic screening for targeted protein degradation: strategies, challenges, and emerging opportunities","volume":"68","author":"Ding","year":"2025","journal-title":"J Med Chem"},{"key":"2025102411450951800_bib29","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1016\/j.apsb.2024.04.007","article-title":"Characteristic roadmap of linker governs the rational design of PROTACs","volume":"14","author":"Dong","year":"2024","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"2025102411450951800_bib30","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.chembiol.2024.02.004","article-title":"PROTAC-mediated degradation of HIV-1 Nef efficiently restores cell-surface CD4 and MHC-I expression and blocks HIV-1 replication","volume":"31","author":"Emert-Sedlak","year":"2024","journal-title":"Cell Chemical Biology"},{"key":"2025102411450951800_bib31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cbpa.2018.05.004","article-title":"Targeted protein degradation and the enzymology of degraders","volume":"44","author":"Fisher","year":"2018","journal-title":"Curr Opin Chem Biol"},{"key":"2025102411450951800_bib32","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/s41422-021-00532-7","article-title":"Degradation of lipid droplets by chimeric autophagy-tethering compounds","volume":"31","author":"Fu","year":"2021","journal-title":"Cell Res"},{"key":"2025102411450951800_bib33","doi-asserted-by":"publisher","first-page":"8657","DOI":"10.1021\/jm5011258","article-title":"Structure-guided design and optimization of small molecules targeting the protein\u2013Protein interaction between the von Hippel\u2013Lindau (VHL) E3 ubiquitin ligase and the Hypoxia inducible factor (HIF) alpha subunit with in vitro nanomolar affinities","volume":"57","author":"Galdeano","year":"2014","journal-title":"J Med Chem"},{"key":"2025102411450951800_bib34","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41586-023-05790-6","article-title":"Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates","volume":"615","author":"Goethals","year":"2023","journal-title":"Nature"},{"key":"2025102411450951800_bib35","doi-asserted-by":"publisher","first-page":"eabe9403","DOI":"10.1126\/science.abe9403","article-title":"Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms","volume":"370","author":"Gordon","year":"2020","journal-title":"Science"},{"key":"2025102411450951800_bib36","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1021\/acsmedchemlett.3c00498","article-title":"Development of a GC-376 based peptidomimetic PROTAC as a degrader of 3-chymotrypsin-like protease of SARS-CoV-2","volume":"15","author":"Grifagni","year":"2024","journal-title":"ACS Med Chem Lett"},{"key":"2025102411450951800_bib37","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1038\/s41467-020-17997-6","article-title":"Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry","volume":"11","author":"Guo","year":"2020","journal-title":"Nat Commun"},{"key":"2025102411450951800_bib135_602_232625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms222312858","article-title":"Development of a PROTAC-based targeting strategy provides a mechanistically unique mode of anti-cytomegalovirus activity","volume":"22","author":"Hahn","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025102411450951800_bib133_160_232125","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1080\/14796694.2024.2377530","article-title":"\u00a0VERITAC-2: a Phase III study of vepdegestrant, a PROTAC ER degrader, versus fulvestrant in ER+\/HER2- advanced breast cancer","volume":"\u00a020","author":"Hamilton","year":"2024","journal-title":"Future Oncol"},{"key":"2025102411450951800_bib38","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1021\/acscentsci.0c00984","article-title":"Targeting the SARS-CoV-2 RNA genome with small molecule binders and ribonuclease Targeting chimera (RIBOTAC) degraders","volume":"6","author":"Haniff","year":"2020","journal-title":"ACS Cent Sci"},{"key":"2025102411450951800_bib39","doi-asserted-by":"publisher","first-page":"16828","DOI":"10.1021\/acs.jmedchem.3c01539","article-title":"Enhanced tumor targeting and penetration of proteolysis-targeting chimeras through iRGD peptide conjugation: a strategy for precise protein degradation in breast cancer","volume":"66","author":"He","year":"2023","journal-title":"J Med Chem"},{"key":"2025102411450951800_bib40","doi-asserted-by":"publisher","first-page":"e2322563121","DOI":"10.1073\/pnas.2322563121","article-title":"Development of an orally bioavailable mSWI\/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer","volume":"121","author":"He","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025102411450951800_bib41","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41594-023-01146-w","article-title":"Co-opting the E3 ligase KLHDC2 for targeted protein degradation by small molecules","volume":"31","author":"Hickey","year":"2024","journal-title":"Nat Struct Mol Biol"},{"key":"2025102411450951800_bib42","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.3390\/cells13242083","article-title":"Discovery of carbonic anhydrase 9 as a novel CLEC2 ligand in a cellular interactome screen","volume":"13","author":"Hoffmann","year":"2024","journal-title":"Cells"},{"key":"2025102411450951800_bib43","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1016\/j.cell.2023.04.009","article-title":"Clp-targeting BacPROTACs impair mycobacterial proteostasis and survival","volume":"186","author":"Hoi","year":"2023","journal-title":"Cell"},{"key":"2025102411450951800_bib44","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41586-024-07089-6","article-title":"Targeted protein degradation via intramolecular bivalent glues","volume":"627","author":"Hsia","year":"2024","journal-title":"Nature"},{"key":"2025102411450951800_bib45","doi-asserted-by":"publisher","first-page":"eadj7251","DOI":"10.1126\/sciadv.adj7251","article-title":"EGFR targeting PhosTACs as a dual inhibitory approach reveals differential downstream signaling","volume":"10","author":"Hu","year":"2024","journal-title":"Sci Adv"},{"key":"2025102411450951800_bib46","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1021\/acs.jmedchem.3c01414","article-title":"Discovery of novel potent and fast BTK PROTACs for the treatment of osteoclasts-related inflammatory diseases","volume":"67","author":"Huang","year":"2024","journal-title":"J Med Chem"},{"key":"2025102411450951800_bib47","doi-asserted-by":"publisher","first-page":"9737","DOI":"10.1128\/JVI.00881-07","article-title":"Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor","volume":"81","author":"Huh","year":"2007","journal-title":"J Virol"},{"key":"2025102411450951800_bib48","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.chom.2009.05.012","article-title":"Ubiquitination, ubiquitin-like modifiers, and deubiquitination in viral infection","volume":"5","author":"Isaacson","year":"2009","journal-title":"Cell Host Microbe"},{"key":"2025102411450951800_bib49","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1038\/s44319-025-00510-9","article-title":"Targeted protein degradation in Escherichia coli using CLIPPERs","volume":"26","author":"Izert-Nowakowska","year":"2025","journal-title":"EMBO Rep"},{"key":"2025102411450951800_bib50","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature10693","article-title":"Vif hijacks CBF-\u03b2 to degrade APOBEC3G and promote HIV-1 infection","volume":"481","author":"J\u00e4ger","year":"2012","journal-title":"Nature"},{"key":"2025102411450951800_bib51","doi-asserted-by":"publisher","first-page":"123401","DOI":"10.1016\/j.lfs.2025.123401","article-title":"Pharmacologically induced proteolysis of histone deacetylase-6 attenuates influenza virus replication despite limited anti-tumor effects","volume":"363","author":"Jungwirth","year":"2025","journal-title":"Life Sci"},{"key":"2025102411450951800_bib52","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/s41467-024-46218-7","article-title":"Homo-BacPROTAC-induced degradation of ClpC1 as a strategy against drug-resistant mycobacteria","volume":"15","author":"Junk","year":"2024","journal-title":"Nat Commun"},{"key":"2025102411450951800_bib53","doi-asserted-by":"publisher","first-page":"6880","DOI":"10.1021\/acs.jmedchem.4c00538","article-title":"Discovery and characterization of a novel cereblon-recruiting PRC1 bridged PROTAC degrader","volume":"67","author":"Kabir","year":"2024","journal-title":"J Med Chem"},{"key":"2025102411450951800_bib54","doi-asserted-by":"publisher","first-page":"14932","DOI":"10.1021\/jacs.3c04640","article-title":"Acetylation targeting Chimera enables Acetylation of the Tumor suppressor p53","volume":"145","author":"Kabir","year":"2023","journal-title":"J Am Chem Soc"},{"key":"2025102411450951800_bib55","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.chembiol.2021.04.007","article-title":"Expanding the arsenal of E3 ubiquitin ligases for proximity-induced protein degradation","volume":"28","author":"Kannt","year":"2021","journal-title":"Cell Chemical Biology"},{"key":"2025102411450951800_bib56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/pharmaceutics16010004","article-title":"Intracellular degradation of SARS-CoV-2\u00a0N-protein caused by modular nanotransporters containing anti-N-protein monobody and a sequence that recruits the Keap1 E3 ligase","volume":"16","author":"Khramtsov","year":"2023","journal-title":"Pharmaceutics"},{"key":"2025102411450951800_bib57","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/anie.201507634","article-title":"Modular PROTAC design for the degradation of oncogenic BCR-ABL","volume":"55","author":"Lai","year":"2016","journal-title":"Angew Chem Int Ed"},{"key":"2025102411450951800_bib58","doi-asserted-by":"publisher","first-page":"7154","DOI":"10.1021\/acs.jmedchem.1c02013","article-title":"Discovery of pentacyclic triterpenoid PROTACs as a class of effective hemagglutinin protein degraders","volume":"65","author":"Li","year":"2022","journal-title":"J Med Chem"},{"key":"2025102411450951800_bib59","doi-asserted-by":"publisher","first-page":"107535","DOI":"10.1016\/j.isci.2023.107535","article-title":"PROTAC targeting cyclophilin A controls virus-induced cytokine storm","volume":"26","author":"Li","year":"2023","journal-title":"iScience"},{"key":"2025102411450951800_bib60","doi-asserted-by":"publisher","first-page":"129680","DOI":"10.1016\/j.bmcl.2024.129680","article-title":"PROTAC\u201d modified dihydroquinolizinones (DHQs) that cause degradation of PAPD-5 and inhibition of hepatitis A virus and hepatitis B virus, in vitro","volume":"102","author":"Li","year":"2024","journal-title":"Bioorg Med Chem Lett"},{"key":"2025102411450951800_bib61","doi-asserted-by":"publisher","first-page":"2405829","DOI":"10.1002\/advs.202405829","article-title":"Discovery of potent degraders of the Dengue virus envelope protein","volume":"11","author":"Li","year":"2024","journal-title":"Adv Sci"},{"key":"2025102411450951800_bib62","doi-asserted-by":"publisher","first-page":"100092","DOI":"10.1016\/j.cellin.2023.100092","article-title":"Antiviral PROTACs: opportunity borne with challenge","volume":"2","author":"Liang","year":"2023","journal-title":"Cell Insight"},{"key":"2025102411450951800_bib63","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.1038\/s41467-024-49161-9","article-title":"Broad-spectrum activity against mosquito-borne flaviviruses achieved by a targeted protein degradation mechanism","volume":"15","author":"Liu","year":"2024","journal-title":"Nat Commun"},{"key":"2025102411450951800_bib64","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.tim.2013.03.006","article-title":"How academic labs can approach the drug discovery process as a way to synergize with big pharma","volume":"21","author":"Loregian","year":"2013","journal-title":"Trends Microbiol"},{"key":"2025102411450951800_bib65","doi-asserted-by":"publisher","first-page":"9694","DOI":"10.1021\/acs.jmedchem.5c00485","article-title":"ByeTAC: bypassing E-ligase-targeting chimeras for direct proteasome degradation","volume":"68","author":"Loy","year":"2025","journal-title":"J Med Chem"},{"key":"2025102411450951800_bib66","doi-asserted-by":"publisher","first-page":"8099","DOI":"10.1021\/acs.jmedchem.4c00193","article-title":"Design of FK866-based degraders for blocking the nonenzymatic functions of nicotinamide phosphoribosyltransferase","volume":"67","author":"Lu","year":"2024","journal-title":"J Med Chem"},{"key":"2025102411450951800_bib67","doi-asserted-by":"publisher","first-page":"129880","DOI":"10.1016\/j.bmcl.2024.129880","article-title":"Discovery of L15 as a novel Vif PROTAC degrader with antiviral activity against HIV-1","volume":"111","author":"Luo","year":"2024","journal-title":"Bioorg Med Chem Lett"},{"key":"2025102411450951800_bib68","doi-asserted-by":"publisher","first-page":"8791","DOI":"10.1021\/acs.jmedchem.4c00131","article-title":"Novel acyl thiourea-based hydrophobic tagging degraders exert potent anti-influenza activity through two distinct endonuclease polymerase acidic-targeted degradation pathways","volume":"67","author":"Ma","year":"2024","journal-title":"J Med Chem"},{"key":"2025102411450951800_bib69","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.chembiol.2025.02.002","article-title":"VIPER-TACs leverage viral E3 ligases for disease-specific targeted protein degradation","volume":"32","author":"Mangano","year":"2025","journal-title":"Cell Chemical Biology"},{"key":"2025102411450951800_bib70","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.immuni.2024.04.025","article-title":"A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death","volume":"57","author":"Mannion","year":"2024","journal-title":"Immunity"},{"key":"2025102411450951800_bib71","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41586-022-05235-6","article-title":"Antibody targeting of E3 ubiquitin ligases for receptor degradation","volume":"610","author":"Marei","year":"2022","journal-title":"Nature"},{"key":"2025102411450951800_bib72","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.pharmthera.2011.04.007","article-title":"Early inhibitors of human cytomegalovirus: state-of-art and therapeutic perspectives","volume":"131","author":"Mercorelli","year":"2011","journal-title":"Pharmacol Ther"},{"key":"2025102411450951800_bib73","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/rmv.558","article-title":"Human cytomegalovirus DNA replication: antiviral targets and drugs","volume":"18","author":"Mercorelli","year":"2008","journal-title":"Rev Med Virol"},{"key":"2025102411450951800_bib74","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/13543784.2021.2010703","article-title":"HPV-induced cancers: preclinical therapeutic advancements","volume":"31","author":"Messa","year":"2022","journal-title":"Expert Opin Investig Drugs"},{"key":"2025102411450951800_bib75","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1021\/acschembio.3c00487","article-title":"Targeted protein degradation through recruitment of the CUL4A complex adaptor protein DDB1","volume":"19","author":"Meyers","year":"2024","journal-title":"ACS Chem Biol"},{"key":"2025102411450951800_bib76","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1021\/acscentsci.3c00015","article-title":"Proximity-induced nucleic acid degrader (PINAD) approach to targeted RNA degradation using small molecules","volume":"9","author":"Mikutis","year":"2023","journal-title":"ACS Cent Sci"},{"key":"2025102411450951800_bib77","doi-asserted-by":"publisher","first-page":"20984","DOI":"10.1038\/s41598-021-00415-2","article-title":"HIV-2 vpx neutralizes host restriction factor SAMHD1 to promote viral pathogenesis","volume":"11","author":"Mohamed","year":"2021","journal-title":"Sci Rep"},{"key":"2025102411450951800_bib78","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.bbrc.2014.10.006","article-title":"Design of a PROTAC that antagonizes and destroys the cancer-forming X-protein of the hepatitis B virus","volume":"453","author":"Montrose","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"2025102411450951800_bib79","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/j.cell.2022.05.009","article-title":"BacPROTACs mediate targeted protein degradation in bacteria","volume":"185","author":"Morreale","year":"2022","journal-title":"Cell"},{"key":"2025102411450951800_bib80","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1021\/acschembio.4c00301","article-title":"A C-degron structure-based approach for the development of ligands targeting the E3 Ligase TRIM7","volume":"19","author":"Mu\u00f1oz\u00a0Sosa","year":"2024","journal-title":"ACS Chem Biol"},{"key":"2025102411450951800_bib81","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41467-025-56317-8","article-title":"Macrocycle-based PROTACs selectively degrade cyclophilin A and inhibit HIV-1 and HCV","volume":"16","author":"Newton","year":"2025","journal-title":"Nat Commun"},{"key":"2025102411450951800_bib82","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41557-023-01379-8","article-title":"Proteolysis-targeting chimeras with reduced off-targets","volume":"16","author":"Nguyen","year":"2024","journal-title":"Nat Chem"},{"key":"2025102411450951800_bib83","doi-asserted-by":"crossref","first-page":"13149","DOI":"10.1039\/D5CC02015H","article-title":"SsrA-based design of BacPROTACs for \u03b2-lactamase degradation in gram-negative bacteria","volume":"61","author":"Nie","year":"2025","journal-title":"Chem Commun"},{"key":"2025102411450951800_bib84","doi-asserted-by":"publisher","first-page":"4556","DOI":"10.1039\/D5CC02015H","article-title":"In vivo knockdown of pathogenic proteins via specific and nongenetic inhibitor of apoptosis protein (IAP)-dependent protein erasers (SNIPERs)","volume":"292","author":"Ohoka","year":"2017","journal-title":"J Biol Chem"},{"key":"2025102411450951800_bib85","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nchembio.2538","article-title":"Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation","volume":"14","author":"Olson","year":"2018","journal-title":"Nat Chem Biol"},{"key":"2025102411450951800_bib86","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1021\/acschembio.6b01068","article-title":"Proteolysis-targeting chimeras: induced protein degradation as a therapeutic strategy","volume":"12","author":"Ottis","year":"2017","journal-title":"ACS Chem Biol"},{"key":"2025102411450951800_bib87","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s43856-025-00863-1","article-title":"Targeted protein degraders of SARS-CoV-2 Mpro are more active than enzymatic inhibition alone with activity against nirmatrelvir resistant virus","volume":"5","author":"Pan","year":"2025","journal-title":"Commun Med"},{"key":"2025102411450951800_bib88","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1021\/acs.jmedchem.4c02068","article-title":"Targeted degradation of HCV polymerase by GalNAc-conjugated ApTACs for pan-genotypic antiviral therapy with high resistance barriers","volume":"68","author":"Pan","year":"2025","journal-title":"J Med Chem"},{"key":"2025102411450951800_bib89","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1016\/j.jhep.2015.02.006","article-title":"From non-A, non-B hepatitis to hepatitis C virus cure","volume":"62","author":"Pawlotsky","year":"2015","journal-title":"J Hepatol"},{"key":"2025102411450951800_bib90","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.aax3769","article-title":"Cellular quality control by the ubiquitin-proteasome system and autophagy","volume":"366","author":"Pohl","year":"2019","journal-title":"Science"},{"key":"2025102411450951800_bib91","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1021\/acs.jmedchem.4c02269","article-title":"Discovery of D-ring-contracted artemisinin as a potent hydrophobic tag for targeted protein degradation","volume":"68","author":"Qing","year":"2025","journal-title":"J Med Chem"},{"key":"2025102411450951800_bib131_687_152225","doi-asserted-by":"publisher","first-page":"7124","DOI":"10.1073\/pnas.1521738113","article-title":"PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer","volume":"113","author":"Raina","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025102411450951800_bib92","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1021\/acschembio.8b00692","article-title":"Quantitative live-cell kinetic degradation and mechanistic profiling of PROTAC mode of action","volume":"13","author":"Riching","year":"2018","journal-title":"ACS Chem Biol"},{"key":"2025102411450951800_bib93","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1021\/acschembio.9b00092","article-title":"SPR-measured dissociation kinetics of PROTAC ternary complexes influence target degradation rate","volume":"14","author":"Roy","year":"2019","journal-title":"ACS Chem Biol"},{"key":"2025102411450951800_bib94","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/ncb2757","article-title":"ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase","volume":"15","author":"Russell","year":"2013","journal-title":"Nat Cell Biol"},{"key":"2025102411450951800_bib95","doi-asserted-by":"publisher","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: chimeric molecules that target proteins to the Skp1\u2013Cullin\u2013F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025102411450951800_bib96","doi-asserted-by":"publisher","first-page":"27248","DOI":"10.1021\/jacs.3c12678","article-title":"A chemical strategy for the degradation of the main protease of SARS-CoV-2 in cells","volume":"145","author":"Sang","year":"2023","journal-title":"J Am Chem Soc"},{"key":"2025102411450951800_bib97","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41573-021-00245-x","article-title":"The PROTACtable genome","volume":"20","author":"Schneider","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"2025102411450951800_bib134_759_232425","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41564-024-01908-2","article-title":"Proteolysis-targeting influenza vaccine strains induce broad-spectrum immunity and in vivo protection","volume":"10","author":"Shen","year":"2025","journal-title":"Nat Microbiol"},{"key":"2025102411450951800_bib98","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/s41587-022-01381-4","article-title":"Generation of a live attenuated influenza A vaccine by proteolysis targeting","volume":"40","author":"Si","year":"2022","journal-title":"Nat Biotechnol"},{"key":"2025102411450951800_bib99","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.chembiol.2022.08.004","article-title":"Target protein localization and its impact on PROTAC-mediated degradation","volume":"29","author":"Simpson","year":"2022","journal-title":"Cell Chemical Biology"},{"key":"2025102411450951800_bib100","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3390\/cells11040741","article-title":"Hepatitis B viral protein HBx and the molecular mechanisms modulating the hallmarks of hepatocellular carcinoma: a comprehensive review","volume":"11","author":"Sivasudhan","year":"2022","journal-title":"Cells"},{"key":"2025102411450951800_bib101","doi-asserted-by":"publisher","first-page":"21662","DOI":"10.1002\/anie.202105942","article-title":"Efficient inhibition of SARS-CoV-2 using chimeric antisense oligonucleotides through RNase L activation","volume":"60","author":"Su","year":"2021","journal-title":"Angew Chem Int Ed"},{"key":"2025102411450951800_bib102","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.1021\/acs.jmedchem.3c02371","article-title":"Uncovering PROTAC sensitivity and efficacy by multidimensional proteome profiling: a case for STAT3","volume":"67","author":"Suo","year":"2024","journal-title":"J Med Chem"},{"key":"2025102411450951800_bib103","doi-asserted-by":"publisher","first-page":"12342","DOI":"10.1021\/acs.jmedchem.3c00861","article-title":"Second-generation AUTACs for targeted autophagic degradation","volume":"66","author":"Takahashi","year":"2023","journal-title":"J Med Chem"},{"key":"2025102411450951800_bib104","doi-asserted-by":"publisher","first-page":"216933","DOI":"10.1016\/j.canlet.2024.216933","article-title":"FLT3-selective PROTAC: enhanced safety and increased synergy with Venetoclax in FLT3-ITD mutated acute myeloid leukemia","volume":"592","author":"Tan","year":"2024","journal-title":"Cancer Lett"},{"key":"2025102411450951800_bib105","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1080\/15548627.2022.2160564","article-title":"The chaperone-assisted selective autophagy complex dynamics and dysfunctions","volume":"19","author":"Tedesco","year":"2023","journal-title":"Autophagy"},{"key":"2025102411450951800_bib106","doi-asserted-by":"publisher","first-page":"115342","DOI":"10.1016\/j.ejmech.2023.115342","article-title":"Bifunctional degraders of cyclin dependent kinase 9 (CDK9): probing the relationship between linker length, properties, and selective protein degradation","volume":"254","author":"Tokarski","year":"2023","journal-title":"Eur J Med Chem"},{"key":"2025102411450951800_bib107","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1021\/acschembio.0c00348","article-title":"A nimbolide-based kinase degrader preferentially degrades oncogenic BCR-ABL","volume":"15","author":"Tong","year":"2020","journal-title":"ACS Chem Biol"},{"key":"2025102411450951800_bib108","doi-asserted-by":"publisher","first-page":"12614","DOI":"10.1021\/acs.jmedchem.3c01303","article-title":"Targeted degradation of alpha-synuclein by autophagosome-anchoring chimera peptides","volume":"66","author":"Tong","year":"2023","journal-title":"J Med Chem"},{"key":"2025102411450951800_bib109","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1021\/acschembio.9b00505","article-title":"Design and characterization of SGK3-PROTAC1, an Isoform specific SGK3 Kinase PROTAC degrader","volume":"14","author":"Tovell","year":"2019","journal-title":"ACS Chem Biol"},{"key":"2025102411450951800_bib110","doi-asserted-by":"publisher","first-page":"273","DOI":"10.37349\/etat.2020.00018","article-title":"Current strategies for the design of PROTAC linkers: a critical review","volume":"1","author":"Troup","year":"2020","journal-title":"Explor Target Antitumor Ther"},{"key":"2025102411450951800_bib111","doi-asserted-by":"publisher","first-page":"e3002550","DOI":"10.1371\/journal.pbio.3002550","article-title":"Alkenyl oxindole is a novel PROTAC moiety that recruits the CRL4DCAF11 E3 ubiquitin ligase complex for targeted protein degradation","volume":"22","author":"Wang","year":"2024","journal-title":"PLoS Biol"},{"key":"2025102411450951800_bib112","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12977-015-0187-z","article-title":"In vivo analysis of Nef\u2019s role in HIV-1 replication, systemic T cell activation and CD4+ T cell loss","volume":"12","author":"Watkins","year":"2015","journal-title":"Retrovirology"},{"key":"2025102411450951800_bib113","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.3390\/ijms26083903","article-title":"Development of peptidomimetic PROTACs as potential degraders of 3-chymotrypsin-like protease of SARS-CoV-2","volume":"26","author":"Wei","year":"2025","journal-title":"Int J Mol Sci"},{"key":"2025102411450951800_bib114","doi-asserted-by":"publisher","first-page":"D1367","DOI":"10.1093\/nar\/gkac946","article-title":"PROTAC-DB 2.0: an updated database of PROTACs","volume":"51","author":"Weng","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"2025102411450951800_bib115","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1038\/s41467-024-48506-8","article-title":"Targeted protein degradation in mycobacteria uncovers antibacterial effects and potentiates antibiotic efficacy","volume":"15","author":"Won","year":"2024","journal-title":"Nat Commun"},{"key":"2025102411450951800_bib116","doi-asserted-by":"publisher","first-page":"8585","DOI":"10.1021\/acs.jmedchem.3c02203","article-title":"Potency-enhanced peptidomimetic VHL ligands with improved oral bioavailability","volume":"67","author":"Wu","year":"2024","journal-title":"J Med Chem"},{"key":"2025102411450951800_bib117","doi-asserted-by":"publisher","first-page":"10917","DOI":"10.1021\/acs.jmedchem.3c00736","article-title":"Small-molecule hydrophobic tagging: a promising strategy of druglike technology for targeted protein degradation","volume":"66","author":"Xie","year":"2023","journal-title":"J Med Chem"},{"key":"2025102411450951800_bib118","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/j.apsb.2025.02.033","article-title":"Discovery and mechanism verification of first-in-class hydrophobic tagging-based degraders of HBV core protein","volume":"15","author":"Xu","year":"2025","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"2025102411450951800_bib119","doi-asserted-by":"publisher","first-page":"100030","DOI":"10.1016\/j.cellin.2022.100030","article-title":"Discovery of oseltamivir-based novel PROTACs as degraders targeting neuraminidase to combat H1N1 influenza virus","volume":"1","author":"Xu","year":"2022","journal-title":"Cell Insight"},{"key":"2025102411450951800_bib120","doi-asserted-by":"publisher","first-page":"110283","DOI":"10.1016\/j.virol.2024.110283","article-title":"A nanobody-based TRIM-away targets the intracellular protein degradation of African swine fever virus","volume":"600","author":"Yang","year":"2024","journal-title":"Virology"},{"key":"2025102411450951800_bib121","doi-asserted-by":"publisher","first-page":"16168","DOI":"10.1021\/acs.jmedchem.3c01521","article-title":"Discovery of potent and selective WDR5 proteolysis targeting chimeras as potential therapeutics for pancreatic cancer","volume":"66","author":"Yu","year":"2023","journal-title":"J Med Chem"},{"key":"2025102411450951800_bib122","doi-asserted-by":"publisher","first-page":"105552","DOI":"10.1016\/j.antiviral.2023.105552","article-title":"Screening of an epigenetic compound library identifies BRD4 as a potential antiviral target for hepatitis B virus covalently closed circular DNA transcription","volume":"211","author":"Yu","year":"2023","journal-title":"Antiviral Res"},{"key":"2025102411450951800_bib123","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1021\/acschembio.5b00216","article-title":"Selective small molecule induced degradation of the BET bromodomain protein BRD4","volume":"10","author":"Zengerle","year":"2015","journal-title":"ACS Chem Biol"},{"key":"2025102411450951800_bib124","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1177\/2472555220985776","article-title":"The vital role of proteomics in characterizing novel protein degraders","volume":"26","author":"Zhang","year":"2021","journal-title":"SLAS Discovery"},{"key":"2025102411450951800_bib132_448_231325","doi-asserted-by":"publisher","first-page":"e202400171","DOI":"10.1002\/cmdc.202400171","article-title":"Structural basis of conformational dynamics in the PROTAC-induced protein degradation","volume":"19","author":"Zhao","year":"2024","journal-title":"ChemMedChem"},{"key":"2025102411450951800_bib125","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1038\/s41467-022-29690-x","article-title":"An anti-influenza A virus microbial metabolite acts by degrading viral endonuclease PA","volume":"13","author":"Zhao","year":"2022","journal-title":"Nat Commun"},{"key":"2025102411450951800_bib126","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.chom.2023.05.030","article-title":"Generation of host-directed and virus-specific antivirals using targeted protein degradation promoted by small molecules and viral RNA mimics","volume":"31","author":"Zhao","year":"2023","journal-title":"Cell Host Microbe"},{"key":"2025102411450951800_bib127","doi-asserted-by":"publisher","first-page":"108437","DOI":"10.1016\/j.bioorg.2025.108437","article-title":"Recent advances in PROTAC-based antiviral and antibacterial therapeutics","volume":"160","author":"Zhou","year":"2025","journal-title":"Bioorg Chem"},{"key":"2025102411450951800_bib128","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13058-023-01695-4","article-title":"SCR-6852, an oral and highly brain-penetrating estrogen receptor degrader (SERD), effectively shrinks tumors both in intracranial and subcutaneous ER + breast cancer models","volume":"25","author":"Zhou","year":"2023","journal-title":"Breast Cancer Res"},{"key":"2025102411450951800_bib129","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1021\/acschembio.3c00645","article-title":"Targeted extracellular protein degradation by dendronized DNA chimeras","volume":"19","author":"Zhu","year":"2024","journal-title":"ACS Chem Biol"},{"key":"2025102411450951800_bib130","doi-asserted-by":"publisher","first-page":"E7285","DOI":"10.1073\/pnas.1803662115","article-title":"Delineating the role of cooperativity in the design of potent PROTACs for BTK","volume":"115","author":"Zorba","year":"2018","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["FEMS Microbiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/femsre\/advance-article-pdf\/doi\/10.1093\/femsre\/fuaf046\/64484973\/fuaf046.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/femsre\/article-pdf\/doi\/10.1093\/femsre\/fuaf046\/64484973\/fuaf046.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/femsre\/article-pdf\/doi\/10.1093\/femsre\/fuaf046\/64484973\/fuaf046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T15:45:13Z","timestamp":1761320713000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femsre\/article\/doi\/10.1093\/femsre\/fuaf046\/8272658"}},"subtitle":[],"editor":[{"given":"Christian","family":"M\u00fcnz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":135,"URL":"https:\/\/doi.org\/10.1093\/femsre\/fuaf046","relation":{},"ISSN":["1574-6976"],"issn-type":[{"value":"1574-6976","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"fuaf046"}}